Search

everythinglearnresearchcommunity

for

Search:↓

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Using testosterone-stimulated weanling rats can effectively replace castrated rats for anti-androgen testing, reducing animal stress.

The TG5 gene affects beef cattle weight, and the CC genotype leads to higher weights.

The new fluoroquinolone effectively fights certain bacteria.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Both penicillamine and tiopronin have significant side effects, but trying the alternative drug can be beneficial if the first is not tolerated.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

A patient with complete hair loss regrew all her hair using tofacitinib.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

CS12192 effectively treats alopecia areata with better safety than current options.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Blocking YAP/TAZ could be a new way to treat skin cancer.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Compound 7p shows strong potential as an anticancer agent.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Using finasteride with TIP extends time off period for prostate cancer patients.